Cases 1 - 8 of 8
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00193
Plaintiff:
Astrazeneca Pharmaceuticals LP and AstraZeneca AB
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
Genzyme Corporation et al v. Mylan Laboratories Limited et al
as 1:2016cv00188
Plaintiff:
Genzyme Corporation , Southern Research Institute and Sanofi-Aventis U.S. LLC
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 28 U.S.C. § 1338
Javelin Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2016cv00059
Plaintiff:
Javelin Pharmaceuticals, Inc. , Hospira, Inc. and Janssen Pharmaceutica N.V.
Defendant:
Mylan Laboratories Limited, Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC et al v. Mylan Laboratories Limited et al
as 1:2015cv00185
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GMBH
Defendant:
Mylan Laboratories Limited, Mylan Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00183
Plaintiff:
Astrazeneca Pharmaceuticals LP , Astrazeneca UK Limited and AstraZeneca AB
Defendant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00145
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. , Boehringer Ingelheim International GmbH , Boehringer Ingelheim Corporation and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
